Literature DB >> 22669525

The development of focal segmental glomerulosclerosis secondary to anabolic steroid abuse.

Patrick Harrington1, Galil Ali, Anthony Chan.   

Abstract

The authors present the case of a patient who presented to the nephrology department of a district general hospital with end-stage renal failure. He presented with malignant hypertension and symptoms and signs of uraemia. He also gave a history of prior abuse of anabolic steroids over a number of years. Renal biopsy was performed and the findings were in keeping with a diagnosis of advanced focal segmental glomerulosclerosis (FSGS). The patient went on to require renal replacement therapy within weeks of presentation. The authors suggest that anabolic steroid abuse is a direct cause of FSGS. People with raised body mass index are known to be at increased risk of developing this condition, due to increased haemodynamic stress on the glomeruli, with subsequent development of sclerosis. However, the authors believe that anabolic steroid abuse may be an independent risk factor, and that anabolic steroids have a direct nephrotoxic effect that leads to a more advanced initial presentation with rapid decline in renal function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22669525      PMCID: PMC3233923          DOI: 10.1136/bcr.07.2011.4531

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

1.  Use of anabolic-androgenic steroids among body builders--frequency and attitudes.

Authors:  M Lindström; A L Nilsson; P L Katzman; L Janzon; J F Dymling
Journal:  J Intern Med       Date:  1990-06       Impact factor: 8.989

2.  Development of focal segmental glomerulosclerosis after anabolic steroid abuse.

Authors:  Leal C Herlitz; Glen S Markowitz; Alton B Farris; Joshua A Schwimmer; Michael B Stokes; Cheryl Kunis; Robert B Colvin; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2009-11-16       Impact factor: 10.121

  2 in total
  6 in total

1.  White matter abnormalities in long-term anabolic-androgenic steroid users: A pilot study.

Authors:  Johanna Seitz; Amanda E Lyall; Gen Kanayama; Nikos Makris; James I Hudson; Marek Kubicki; Harrison G Pope; Marc J Kaufman
Journal:  Psychiatry Res Neuroimaging       Date:  2016-12-10       Impact factor: 2.376

Review 2.  Anabolic androgenic steroid abuse in the United Kingdom: An update.

Authors:  Carrie Mullen; Benjamin J Whalley; Fabrizio Schifano; Julien S Baker
Journal:  Br J Pharmacol       Date:  2020-03-03       Impact factor: 8.739

Review 3.  Nephrotoxic effects of common and emerging drugs of abuse.

Authors:  William F Pendergraft; Leal C Herlitz; Denyse Thornley-Brown; Mitchell Rosner; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237

4.  The Case: Chronic Kidney Disease Unmasked by Single-Subject Research.

Authors:  Benjamin Gollasch; Oskar Wischnewski; Birgit Rudolph; Yoland-Marie Anistan; Friedrich C Luft; Maik Gollasch
Journal:  Case Rep Nephrol Dial       Date:  2018-05-16

5.  The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review.

Authors:  Dorna Davani-Davari; Iman Karimzadeh; Hossein Khalili
Journal:  BMC Nephrol       Date:  2019-05-31       Impact factor: 2.388

Review 6.  Traditional Chinese Medicine in Treating Primary Podocytosis: From Fundamental Science to Clinical Research.

Authors:  Lirong Lin; En Tian; Jiangwen Ren; Zhifeng Wu; Junhui Deng; Jurong Yang
Journal:  Front Pharmacol       Date:  2022-08-08       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.